Sökning: WFRF:(Munch Andreas) >
Undiagnosed microsc...
Undiagnosed microscopic colitis : a hidden cause of chronic diarrhoea and a frequently missed treatment opportunity
-
- Münch, Andreas, 1970- (författare)
- Linköpings universitet,Avdelningen för molekylär medicin och virologi,Medicinska fakulteten,Region Östergötland, Mag- tarmmedicinska kliniken
-
- Sanders, David S. (författare)
- Royal Hallamshire Hosp, England
-
- Molloy-Bland, Michael (författare)
- Oxford PharmaGenesis, Australia
-
visa fler...
-
- Hungin, A. Pali S. (författare)
- Newcastle Univ, England
-
visa färre...
-
(creator_code:org_t)
- 2019-07-05
- 2020
- Engelska.
-
Ingår i: FRONTLINE GASTROENTEROLOGY. - : BMJ Publishing Group Ltd. - 2041-4137 .- 2041-4145. ; 11:3, s. 228-234
- Relaterad länk:
-
https://liu.diva-por... (primary) (Raw object)
-
visa fler...
-
https://fg.bmj.com/c...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Microscopic colitis (MC) is a treatable cause of chronic, non-bloody, watery diarrhoea, but physicians (particularly in primary care) are less familiar with MC than with other causes of chronic diarrhoea. The colon in patients with MC is usually macroscopically normal. MC can only be diagnosed by histological examination of colonic biopsies (subepithelial collagen band >10 mu m (collagenous colitis) or >20 intraepithelial lymphocytes per 100 epithelial cells (lymphocytic colitis), both with lamina propria inflammation). The UK National Health Service exerts downward pressure to minimise colonoscopy referrals. Furthermore, biopsies are often not taken according to guidelines. These factors work against MC diagnosis. In this review, we note the high incidence of MC (comparable to ulcerative colitis and Crohns disease) and its symptomatic overlap with irritable bowel syndrome. We also highlight problems with the recommendation by National Health Service/National Institute for Health and Care Excellence guidelines for inflammatory bowel diseases that colonoscopy referrals should be based on a faecal calprotectin level of >= 100 mu g/g. Faecal calprotectin is <100 mu g/g in over half of individuals with active MC, building into the system a propensity to misdiagnose MC as irritable bowel syndrome. This raises important questions-how many patients with MC have already been misdiagnosed, and how do we address this silent burden? Clarity is needed around pathways for MC management; MC is poorly acknowledged by the UK healthcare system and it is unlikely that best practices are being followed adequately. There is an opportunity to identify and treat patients with MC more effectively.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Gastroenterologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)
Nyckelord
- inflammatory bowel disease; collagenous colitis; lymphocytic colitis; colonoscopy; histopathology
Publikations- och innehållstyp
- ref (ämneskategori)
- for (ämneskategori)
Hitta via bibliotek
Till lärosätets databas